4//SEC Filing
McElhaugh Michael J. 4
Accession 0001447028-23-000011
CIK 0001447028other
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 4:12 PM ET
Size
10.9 KB
Accession
0001447028-23-000011
Insider Transaction Report
Form 4
McElhaugh Michael J.
DirectorInterim President & CEO
Transactions
- Award
Stock Option (Right to Buy)
2023-02-01+334,700→ 334,700 totalExercise: $2.90Exp: 2033-02-01→ Common Shares (334,700 underlying) - Award
Common Shares
2023-02-01+83,700→ 1,391,157 total
Footnotes (2)
- [F1]Represents the grant of restricted stock units ("RSUs"), which represent a contingent right to receive one common share for each RSU. The RSUs vest in three equal annual installments beginning one year from the grant date, subject to the Reporting Person's continuous service as of each vesting date. Unless otherwise provided, on each vesting date, common shares will automatically be sold to satisfy the Reporting Person's tax withholding obligations in a non-discretionary transaction.
- [F2]This option vests over a four-year period, with 1/48th of the shares subject to the option vesting in substantially equal monthly installments measured from one month following the grant date, subject to the Reporting Person's continuous service as of each vesting date.
Issuer
Arbutus Biopharma Corp
CIK 0001447028
Entity typeother
Related Parties
1- filerCIK 0001635326
Filing Metadata
- Form type
- 4
- Filed
- Feb 2, 7:00 PM ET
- Accepted
- Feb 3, 4:12 PM ET
- Size
- 10.9 KB